HIGHLIGHTS
- who: from the The Netherlands The Netherlands have published the research: Implantable mechanical circulatory support in The Netherlands, in the Journal: (JOURNAL)
SUMMARY
Editor`s Comment Neth Heart J Implantable mechanical circulatory support in Adverse events, however, remained a major issue with 19% stroke rates, 12% pump thrombosis and 52% bleeding complications. These strategies definitely became a topic after the introduction of the 3rd generation centrifugal devices, HeartMate 3 and HeartWare HVAD, in 2016. The outcomes in the study support that claim reporting a significant lower pump thrombosis and cerebrovascular event rate for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.